Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

Interviews Startup of the month Prevention instead of just treating the symptoms Intestinal flora is a term that many people would prefer never to talk about. Yet it has a massive impact on physical health. The founding team of Biomes wants to change this - and revolutionize the healthcare system...

Sophie Zeller 01.01.1970

News 64 million euros for Cardior The biotech company from Hanover is delighted with an oversubscribed Series B financing round. The start-up now wants to press ahead with the development of its heart drug.

Lars-Thorben Niggehoff 01.01.1970

News Mk2 Biotechnologies closes seed financing round The Munich-based start-up has raised several million euros in a seed financing round. In autumn, the company will move into a biotechnology start-up center.

Lisa Marie Münster 01.01.1970

News Contact lens for the ear comes onto the market The Mannheim-based start-up Vibrosonic is launching its "hearing contact lens" on the market. The device is invisible and is said to be better than normal hearing aids.

Tom Schmidtgen 01.01.1970

News Atai receives 130 million euros With the current financing round, the biotech company Atai is said to be worth 1.7 billion euros. The round was led by German investor Christian Angermayer.

Lisa Marie Münster 01.01.1970

News Nine million euros for GeneQuine Biotherapeutics The money will be used to develop a gene therapy. The company already holds a European patent.

Tom Schmidtgen 01.01.1970

News Bayer leads the Series B financing of Senti Bio Senti Bio receives 105 million US dollars. The financing round was led by Bayer. Senti Biosciences receives an investment of 105 million US dollars. Among the investors is Leaps by Bayer, the investment arm of Bayer...

Tom Schmidtgen 01.01.1970

1
2
3